Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Gynecologic Neoplasms 31. March 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 16333  Previews Next
   
   Articles 1 - 20 / 326655  
   
Viewpoint on the Consequences and Mitigation of Cognitive Bias in the Radiological Interpretation of Breast Cancer Imaging Using Artificial Intelligence.
JMIR Med Inform
Conti L, Capetti B, Battaglia O, Grasso R, Pesapane F, Monzani D, Pravettoni G.
PMID: 41911478 [PubMed - indexed for MEDLINE]


Motor Imagery and Action Observation in Breast Cancer Survivors: Protocol for a Randomized Controlled Trial.
JMIR Res Protoc
Arnal-Vallés MP, Soto-Ruiz N, Bays-Moneo AB, García-Vivar C, Escalada-Hernández P.
PMID: 41911468 [PubMed - indexed for MEDLINE]


Deep inspiration breath hold versus free breathing in postoperative radiotherapy strategy for patients with left-sided breast cancer treated with volumetric modulated arc therapy: A meta-analysis and systematic review.
PLoS One
Chiang PY, Huang PJ, Hung CH, Lin CP, Chang CC.
PMID: 41911243 [PubMed - indexed for MEDLINE]


Design-analysis mismatch in the analysis of longitudinal HER2 data in breast cancer.
Cancer
Chen I.
PMID: 41911053 [PubMed - indexed for MEDLINE]


A Retrospective Observational Study of Safety and Effectiveness of Abemaciclib in Chinese Patients with Breast Cancer.
Adv Ther
Zhao F, Liu Y, Jiang H, Yang L, Zhu Q, Ma X, Li H, Zhan Q.
PMID: 41910936 [PubMed - as supplied by publisher]


Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.
Breast Cancer
Aoyama Y, Kashiwabara K, Kikawa Y, Taira N, Mukai H, Takahashi M.
PMID: 41910921 [PubMed - as supplied by publisher]


OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer.
Breast Cancer Res Treat
Rugo HS, Pluard TJ, Sharma P, Melisko M, Al-Jazayrly G, Ji Y, Vidula N, Ellerton J, Smakal M, Zimovjanova M, Weng D.
PMID: 41910867 [PubMed - indexed for MEDLINE]


Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy.
Breast Cancer Res Treat
Tavares GM, Ramalho SOB, da Silva LR, Telles GD, de Paiva Silva GR, Torresan RZ, Derchain SFM.
PMID: 41910838 [PubMed - indexed for MEDLINE]


Awareness of women with gynecologic cancer about their disease: evidence from İzmir, Turkey.
Afr J Reprod Health
Balc, Abdulmecit Öktem A, Öztürk YK, Merder D, Alan Y, Alan M.
PMID: 41910468 [PubMed - indexed for MEDLINE]


Dosimetric evaluation of the tangential and supraclavicular breast radiotherapy fields junction in mono and dual isocentric techniques with practical measurement and comparison versus TomoDirect technique.
J Cancer Res Ther
Mirzaie H, Banaee N, Nedaie HA, Samaei N.
PMID: 41910299 [PubMed - indexed for MEDLINE]


The effect of perioperative lidocaine during modified radical mastectomy on postoperative pain and immune response: A randomized clinical trial.
J Cancer Res Ther
Hadavi SMR, Sahmeddini MA, Khademi S, Boostani N.
PMID: 41910294 [PubMed - indexed for MEDLINE]


Real-world treatment patterns and outcomes in Indian patients with HR+/HER2- advanced breast cancer treated with palbociclib.
J Cancer Res Ther
Rajappa S, Bapna A, Arya D, Desai C, Shah M, Walia M.
PMID: 41910292 [PubMed - indexed for MEDLINE]


Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study.
J Cancer Res Ther
Gandhi AK, Rastogi M, Sharma V, Bhutia TD, Ramola D, Singh N, Das PK, Raj G, Singh P, Sharma DN.
PMID: 41910290 [PubMed - indexed for MEDLINE]


Identifying high-risk groups for recurrence in endometrial cancer: The role of ESMO-ESGO-ESTRO risk classification.
J Cancer Res Ther
Elçiçek ÖF, Yalici Ö, Karaboyun K, , Karaba, Çavdar E, Bilen YG, Karaduman , Avci O, Seber ES.
PMID: 41910289 [PubMed - indexed for MEDLINE]


Regulatory effects of miRNA in epithelial ovarian cancer patients: A case-control study from Eastern India.
J Cancer Res Ther
Kumari S, Balamurugan R, Majumdar SKD, Muduly DK.
PMID: 41910287 [PubMed - indexed for MEDLINE]


Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka.
J Cancer Res Ther
Sindhu KR, Pranitha SL, Arpitha S, Narayanan GS, Namratha K.
PMID: 41910282 [PubMed - indexed for MEDLINE]


Assessment of acute skin reactions in hypofractionated chest wall irradiation on a telecobalt machine for breast cancer.
J Cancer Res Ther
Manjunath GN, Raj MK, Kulal S.
PMID: 41910281 [PubMed - indexed for MEDLINE]


Insights into the gut microbiome-metabolite dynamics in breast cancer.
Gut Microbes Rep
Manzoor H, Kayani MUR.
PMID: 41909891 [PubMed]


Engineering immune-competent niches: strategies, applications, and translational hurdles in ovarian cancer organoid models.
Front Immunol
Chen Y, Xu N, Dong M, Liu W, Liu Z, Sun G, Jia Y.
PMID: 41909670 [PubMed - indexed for MEDLINE]


Neuro-immune crosstalk in breast cancer: molecular mechanisms from stress signals to immune escape.
Front Immunol
Ni G, Qian N, Jiang Y, Tian R, Huang T, Li S.
PMID: 41909651 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 326655    Page 1 of 16333  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1